Abhay Pandit

scientific committee | AEP | Speakers | Abhay Pandit

abhay-pandit

Abhay Pandit, PhD, Established Professor of Biomaterials at the National University of Ireland, Galway, is Director of the Centre for Research in Medical Devices (CÚRAM), a multi-disciplinary translational research centre. CÚRAM coordinated by NUI Galway is a leading global hub of expertise in medical technology that amalgamates fundamental and applied science to drive the translation of clinician- and industry-informed research into next-generation medical devices and implants. CÚRAM brings together researchers from NUI Galway, UCD, DCU, UL, UCC and RCSI and 40 industry partners, including indigenous Irish companies and multi-nationals, to support product development and the creation of new spin-out companies.

Prof. Pandit has filed 22 patents (4 granted) and has licensed three technologies for peripheral nerve, spinal cord repair and hernia repair to medical device companies. To date, he has raised over € 78 M in research funding. He has published over 185 papers in peer reviewed journals.

Prof Pandit has been elected as a Fellow of the Tissue Engineering and Regenerative International Society and an International Fellow in Biomaterials Science and Engineering by the International Union of Societies for Biomaterials Science and Engineering (IUSBSE). He is the first Irish academic to bestowed with these fellowships.

He is the recipient of numerous awards and honors, including the prestigious Johnson and Johnson Healthcare Innovation Programme Award. In his industry career; Prof Pandit secured FDA clearance for a commercial wound dressing and IDE approval for a collagen-based vascular sealant. In recognition of his track record in technology transfer, Prof Pandit secured the Academic/Emerging Medical Technology Company of the Year-Silver Award for 2013. The awards, established in 2007, are supported by Irish Medical Devices Association (IMDA), Enterprise Ireland and IDA Ireland.

Professor Pandit’s research interests’ focus on the development of next generation targeted controlled-drug-release reservoir delivery vehicles with high payload capacity, programmable degradation profiles and inbuilt gradients of physical, chemotropic and protective cues which facilitate spatiotemporal localised delivery of multiple biomolecules to target injury mechanisms at the molecular and cellular levels. These macromolecular complexes form functional interfaces between implanted devices and biological systems to endow the former with bio-responsiveness and/or biological function.